Skip to main content

Table 4 Multivariable analysis of OS and DFS in patients received NAC (n = 31)

From: CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Variable

OS

DFS

HR

95%CI

p value

HR

95%CI

p value

Post-NAC CMTM1_v17

 Low vs high

0.074

0.008–0.670

0.021

0.455

0.136–1.517

0.12

Pathological stage

 I/II vs III

0.295

0.082–1.049

0.059

0.319

0.107–0.951

0.04

Age

  ≤ 55 vs > 55

   

0.291

0.923–0.915

0.035

  1. P value was calculated using a two-sided log-rank test.
  2. OS overall survival, DFS disease-free survival, HR hazard ratio (log-rank), CI confidence interval.
  3. Bold values are significant (P < 0.05)